Rigel Pharmaceuticals CEO Raul Rodriguez's 2018 pay jumps 83% to $4M
Rigel Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 1, 2020
Rigel Pharmaceuticals reported fiscal year 2018 executive compensation information on April 1, 2020.
In 2018, six executives at Rigel Pharmaceuticals received on average a compensation package of $1.9M, a 70% increase compared to previous year.
Average pay of disclosed executives at Rigel Pharmaceuticals
Raul R. Rodriguez, Chief Executive Officer, received $4M in total, which increased by 83% compared to 2017. 69% of Rodriguez's compensation, or $2.7M, was in option awards. Rodriguez also received $608K in non-equity incentive plan, $637K in salary, as well as $3.4K in other compensation.
Dolly A. Vance, General Counsel, received a compensation package of $1.8M, which increased by 57% compared to previous year. 49% of the compensation package, or $863K, was in option awards.
Anne-Marie Duliege, Chief Medical Officer, earned $1.7M in 2018, a 58% increase compared to previous year.
Eldon C. Mayer, III, Executive Vice President, Chief Commercial Officer, received $1.6M in 2018, which increases by 122% compared to 2017.
Esteban Masuda, Executive Vice President, Research, earned $1.3M in 2018, a 104% increase compared to previous year.
Dean L. Schorno, Chief Financial Officer, received $1.2M in 2018.
Related executives
Esteban Masuda
Rigel Pharmaceuticals
Executive Vice President, Research
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
Dean Schorno
Rigel Pharmaceuticals
Chief Financial Officer
Dolly Vance
Rigel Pharmaceuticals
Executive Vice President, Corporate Affairs, General
Anne-Marie Duliege
Rigel Pharmaceuticals
Chief Medical Officer
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
You may also like
Source: SEC filing on April 1, 2020.